All Pathways
UrologyEmergency

Acute Ischemic Priapism Management (AUA/SMSNA 2021)

Acute Ischemic Priapism Management (AUA/SMSNA 2021): Priapism >4 Hours → Ischemic or Non-Ischemic? → ⚠️ ISCHEMIC PRIAPISM = EMERGENCY → Duration >36 Hou...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Priapism >4 Hours

    Persistent erection unrelated to sexual stimulation

    1. Decision

      Ischemic or Non-Ischemic?

      Critical first step - treatment differs significantly

      • ISCHEMIC (low-flow): Painful, rigid, no trauma
      • NON-ISCHEMIC (high-flow): Not painful, partial tumescence, trauma history
      • Blood gas: Ischemic = dark blood, pO2 <30, pH <7.25
      • Blood gas: Non-ischemic = bright red, pO2 >90, pH normal
      1. Warning

        ⚠️ ISCHEMIC PRIAPISM = EMERGENCY

        Compartment syndrome of the penis - treat immediately

        • Smooth muscle damage begins at 4-6 hours
        • Irreversible damage by 24-48 hours
        • Risk: Permanent erectile dysfunction
        • Do NOT delay treatment
        1. Decision

          Duration >36 Hours?

          Extended duration affects treatment approach

          1. Action

            First-Line: ICI + Aspiration

            Intracavernous phenylephrine + corporal aspiration

            • 19-21g butterfly needle into corpus
            • Aspirate dark blood until bright red
            • Phenylephrine 100-500 mcg/mL
            • Inject 1 mL every 3-5 minutes
            • Max ~1000 mcg (1 mg) total
            • May irrigate with saline
            1. Action

              Phenylephrine Preparation

              Dilute to 100-500 mcg/mL

              • 1 mg (1 mL of 1mg/mL) in 9 mL NS = 100 mcg/mL
              • Or use 200-500 mcg/mL concentration
              • Inject 1 mL every 3-5 minutes
              • Continue until detumescence or max dose
              1. Warning

                ⚠️ Monitor During ICI

                Cardiovascular monitoring required

                • Monitor BP and HR continuously
                • Stop if severe HTN, bradycardia, arrhythmia
                • Caution in cardiac disease
                • Have resuscitation equipment available
                • Avoid epinephrine (mixed alpha/beta)
                1. Decision

                  Detumescence Achieved?

                  Assess response after ICI + aspiration

                  1. Outcome

                    Detumescence Achieved

                    Continue monitoring, urology follow-up

                    • Observe for recurrence
                    • Discharge with urology follow-up
                    • Counsel on ED risk
                    • Address underlying cause (PDE5i, injection therapy)
                  2. Action

                    Distal Corporoglanular Shunt

                    Second-line surgical intervention

                    • Winter shunt: Biopsy needle through glans
                    • Ebbehoj shunt: Scalpel through glans
                    • T-shunt: Scalpel + dilation
                    • Creates fistula between glans and corpora
                    • May add tunneling if unsuccessful
                    1. Action

                      Corporal Tunneling

                      If distal shunt fails

                      • Dilator passed through shunt site
                      • Creates channel to evacuate clot
                      • Proximal shunts (Quackels, Grayhack) if all else fails
                      • Higher complication rate
                      1. Outcome

                        High Risk of ED

                        Prolonged priapism often results in permanent ED

                    2. Action

                      Consider Early Prosthesis

                      In refractory cases or prolonged duration

                      • Discuss with patient early
                      • May prevent corporal fibrosis
                      • Easier insertion before fibrosis develops
                      • Alternative to repeated shunts
          2. Action

            Prolonged Priapism (>36h)

            ICI less effective - consider primary shunt

            • Smooth muscle may not respond to sympathomimetics
            • Aspiration + ICI can still be attempted
            • Lower threshold for proceeding to shunt
            • Discuss realistic outcomes with patient
      2. Action

        Non-Ischemic Priapism

        Not an emergency - can observe

        • Usually follows perineal/penile trauma
        • Initial management is conservative
        • Ice, observation, compression
        • Selective embolization if persistent
        • Urology follow-up

Guideline Source

Acute Ischemic Priapism: An AUA/SMSNA Guideline

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address non-ischemic (high-flow) priapism in detail
  • Stuttering priapism requires different management approach
  • Pediatric dosing not addressed
  • Does not cover ED dysfunction management post-priapism
  • Sickle cell disease may require additional hematology input

Contraindicated Populations

pediatric_dosing_not_specified

Applicable Regions

USEU

EU: EAU guidelines also recommend phenylephrine as first-line sympathomimetic

US: AUA/SMSNA 2021 guideline - phenylephrine is agent of choice

Version 1Next review: 2028-01-11

Frequently Asked Questions

What is the Acute Ischemic Priapism Management (AUA/SMSNA 2021)?

The Acute Ischemic Priapism Management (AUA/SMSNA 2021) is a emergency clinical algorithm for Urology. It provides a structured decision tree to guide clinical decision-making, based on Acute Ischemic Priapism: An AUA/SMSNA Guideline.

What guideline is the Acute Ischemic Priapism Management (AUA/SMSNA 2021) based on?

This algorithm is based on Acute Ischemic Priapism: An AUA/SMSNA Guideline (DOI: 10.1097/JU.0000000000002236).

What are the limitations of the Acute Ischemic Priapism Management (AUA/SMSNA 2021)?

Known limitations include: Does not address non-ischemic (high-flow) priapism in detail; Stuttering priapism requires different management approach; Pediatric dosing not addressed; Does not cover ED dysfunction management post-priapism; Sickle cell disease may require additional hematology input. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Ischemic Priapism Management (AUA/SMSNA 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free